NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON

Vendor Intelligence Report: EHZ Peptides

Published 12 Nov 2026. 33-page investigative report on who is behind EHZ Peptides: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Across 75 Finnrick lab tests, EHZ Peptides records 56 pass / 19 fail — an overall pass rate of 75%. The useful read is product-specific: retatrutide and tirzepatide are the comparatively defensible choices, while tesamorelin is the clearest avoid signal and GHK-Cu carries an identity-failure warning that purity numbers alone do not solve. The report also shows ratings can move under stricter scoring, so the Appendix breakdown matters.

Beyond the lab record, EHZ is a young public storefront with an older documentation trail. Its site publishes a broad wholesale catalogue and factory-direct claims, but it does not disclose a legal entity, address, owner, technical lead, batch-release authority, or merchant of record. A verified US Google Ads advertiser and an inferred California commercial vehicle appear in the operator chain, while ultimate ownership remains unresolved.

The strongest non-test concern is the COA layer. EHZ presents a 114-record library, but sampled files include a PT-141 report whose visible fields differ from the underlying Peptide Mom / Nanjing / Brown Biology text layer, plus a KLOW80 report generated under the EHZ brand with no named lab. Nanjing Peptide appears to be a real manufacturer, yet its official-brand list excludes EHZ and its verification portal marked EHZ-associated numbers unauthorized.

This is not a blanket fake-product conclusion: Finnrick's independent data supports some EHZ products better than others. It is a traceability and recourse problem, especially for buyers relying on vendor COAs, factory-direct language, representative-issued payment instructions, or search-result doorway pages rather than lot-level independent testing.

Inside the full report:

  • Per-product pass/fail rates, rating trajectories, and methodology-divergence charts for all 6 tested products
  • PDF forensics on the PT-141 overlay and EHZ-generated KLOW80 COA
  • COA-library analysis covering 114 records and the Brown Biology verification problem
  • Operator-chain research linking Google Ads, Planorivexium LLC, and unresolved UBO status
  • Nanjing Peptide official-brand and phone-verification checks against EHZ contacts
  • Payment, recourse, reputation, and SEO doorway-risk assessment

Risk assessment

  • COA/documentation-authenticity risk — high: EHZ’s 114-record COA library includes re-skinned/re-dated Peptide Mom/Nanjing documents and vendor-generated KLOW80 paperwork; affects any product where the buyer relies on EHZ COAs.
  • Unauthorized-channel and manufacturer-claim risk — high: Nanjing Peptide’s official-brand list excludes EHZ and its portal marked EHZ-associated WhatsApp numbers unauthorized, contradicting factory-direct marketing.
  • Ownership and buyer-recourse opacity risk — high: No disclosed EHZ legal entity, address, owner, or merchant of record was found; Planorivexium/Alen Sabolcec is an inferred commercial layer, not confirmed ownership or recourse.
  • Product-specific quality risk: tesamorelin — high: Tesamorelin is EHZ’s weakest tested line at 37.08%, with 7 tests and 1 pass / 6 fail.
  • Product-specific quality risk: BPC-157 and cagrilintide — medium: BPC-157 is 50.19% with 6 tests and 3 pass / 3 fail; cagrilintide is 50.16% with 3 tests and 1 pass / 2 fail.
  • GHK-Cu identity-verification risk — medium: GHK-Cu rates 80.91% overall, but the record includes 2 fails and a field-reviewed identity failure in which a sample did not contain GHK-Cu.
  • Copycat and brand-confusion risk — medium: EHZ-referencing parasite pages and Peptide Mom / peptideai doorway context were found; EHZ provides no strong official-channel, anti-counterfeit, or signed-COA verification program.